16 HOW SUPPLIED/STORAGE AND HANDLING
PRISTIQ (desvenlafaxine) extended-release tablets are available as follows:
25 mg, tan, square pyramid tablet debossed with "W" (over) "25" on the flat side
-
- NDC 0008-1210-30, bottle of 30 tablets in unit-of-use package
50 mg, light pink, square pyramid tablet debossed with "W" (over) "50" on the flat side
-
- NDC 0008-1211-14, bottle of 14 tablets in unit-of-use package
-
- NDC 0008-1211-30, bottle of 30 tablets in unit-of-use package
-
- NDC 0008-1211-01, bottle of 90 tablets in unit-of-use package
-
- NDC 0008-1211-50, 10 blisters of 10 (HUD)
100 mg, reddish-orange, square pyramid tablet debossed with "W" (over) "100" on the flat side
-
- NDC 0008-1222-14, bottle of 14 tablets in unit-of-use package
-
- NDC 0008-1222-30, bottle of 30 tablets in unit-of-use package
-
- NDC 0008-1222-01, bottle of 90 tablets in unit-of-use package
-
- NDC 0008-1222-50, 10 blisters of 10 (HUD)
Store at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature].
Each tablet contains 38 mg, 76 mg or 152 mg of desvenlafaxine succinate equivalent to 25 mg, 50 mg or 100 mg of desvenlafaxine, respectively.